Literature DB >> 1973824

Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.

S C Hyde1, P Emsley, M J Hartshorn, M M Mimmack, U Gileadi, S R Pearce, M P Gallagher, D R Gill, R E Hubbard, C F Higgins.   

Abstract

The ATP-binding cassette (ABC) superfamily of transport systems now includes over thirty proteins that share extensive sequence similarity and domain organization. This superfamily includes the well characterized periplasmic binding protein-dependent uptake systems of prokaryotes, bacterial exporters, and eukaryotic proteins including the P-glycoprotein associated with multidrug resistance in tumours (MDR), the STE6 gene product that mediates export of yeast a-factor mating pheromone, pfMDR that is implicated in chloroquine resistance of the malarial parasite, and the product of the cystic fibrosis gene (CFTR). Here we present a tertiary structure model of the ATP-binding cassettes characteristic of this class of transport system, based on similarities between the predicted secondary structures of members of this family and the previously determined structure of adenylate kinase. This model has implications for both the molecular basis of transport and cystic fibrosis and provides a framework for further experimentation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973824     DOI: 10.1038/346362a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  269 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 2.  Mechanism of coupling of transport to hydrolysis in bacterial ATP-binding cassette transporters.

Authors:  Amy L Davidson
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

3.  Biochemical and X-ray crystallographic studies on shikimate kinase: the important structural role of the P-loop lysine.

Authors:  T Krell; J Maclean; D J Boam; A Cooper; M Resmini; K Brocklehurst; S M Kelly; N C Price; A J Lapthorn; J R Coggins
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

4.  Characterization of a variant of vga(A) conferring resistance to streptogramin A and related compounds.

Authors:  J Haroche; J Allignet; C Buchrieser; N El Solh
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Structural cues involved in endoplasmic reticulum degradation of G85E and G91R mutant cystic fibrosis transmembrane conductance regulator.

Authors:  X Xiong; A Bragin; J H Widdicombe; J Cohn; W R Skach
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

6.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

7.  Mechanism of ABC transporters: a molecular dynamics simulation of a well characterized nucleotide-binding subunit.

Authors:  Peter M Jones; Anthony M George
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

8.  Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis.

Authors:  H Bolhuis; D Molenaar; G Poelarends; H W van Veen; B Poolman; A J Driessen; W N Konings
Journal:  J Bacteriol       Date:  1994-11       Impact factor: 3.490

9.  Effects of the delta F508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR.

Authors:  P J Thomas; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1993-02       Impact factor: 2.945

10.  Ketoconazole activates Cl- conductance and blocks Cl- and fluid absorption by cultured cystic fibrosis (CFPAC-1) cells.

Authors:  U Kersting; D Kersting; K R Spring
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.